Abbot Laboratories (Pakistan) Ltd
Shariah compliantAlmost no debt, a steady dividend, a strong business and the price in an uptrend. No read is against it.
Working
- P/E 10.6 against a sector median of 11.9.
- Debt is 1% of equity in the latest quarter.
- Profit up 40% on the same quarter last year.
To watch
- Revenue up 4% on the same quarter last year.
- Yield 4.0% at today's price.
- Raised last year, from Rs 10.00 to Rs 40.00.
Keep reading ABOT: business, price trend and value
How good the business is, where its support zone sits, what it may be worth, its health, dividends, peers and latest results open with a free account.
Latest results
Quarter: Jul–Sep 2026In the Jul–Sep 2026 quarter, ABOT's sales rose 4% to Rs 20.6bn, from Rs 19.8bn, and profit after tax rose 40% to Rs 2.5bn, from Rs 1.8bn (compared with Jul–Sep 2025).
Earnings per share were Rs 25.99, against Rs 18.62 a year earlier.
At Rs 1009.02, ABOT trades at 11.1 times earnings, with a dividend yield of 4.0%.
- P/E ratio
- 11.1
- Dividend yield
- 4.0%
- Dividend payout
- 0%
- of earnings
- Return on equity
- 27%
- Net margin
- 12.0%
- last 12 months
- Debt to equity
- 0.01
ABOT quarterly results
Reported figures| Quarter | Sales | Profit after tax | Net margin | EPS | Dividend / share |
|---|---|---|---|---|---|
| Jul–Sep 2026 | Rs 20.6bn | Rs 2.5bn | 12.3% | Rs 25.99 | — |
| Apr–Jun 2026 | Rs 20.3bn | Rs 2.2bn | 10.8% | Rs 22.47 | — |
| Jan–Mar 2026 | Rs 17.7bn | Rs 1.9bn | 11.0% | Rs 19.82 | — |
| Oct–Dec 2025 | Rs 19.2bn | Rs 2.6bn | 13.6% | Rs 26.56 | Rs 40.00 |
| Jul–Sep 2025 | Rs 19.8bn | Rs 1.8bn | 9.2% | Rs 18.62 | — |
| Apr–Jun 2025 | Rs 19.1bn | Rs 1.9bn | 10.2% | Rs 19.85 | — |
| Jan–Mar 2025 | Rs 17.3bn | Rs 1.6bn | 9.2% | Rs 16.34 | — |
| Oct–Dec 2024 | Rs 18.6bn | Rs 1.3bn | 6.9% | Rs 13.12 | Rs 10.00 |
ABOT annual results and dividends
Reported figures| Year | Sales | Profit after tax | EPS | Dividend / share |
|---|---|---|---|---|
| Year to Dec 2025 | Rs 75.4bn | Rs 8.0bn | Rs 81.37 | Rs 40.00 |
| Year to Dec 2024 | Rs 68.2bn | Rs 5.2bn | Rs 53.46 | Rs 10.00 |
| Year to Dec 2023 | Rs 55.5bn | Rs 262.0mn | Rs 2.67 | — |
| Year to Dec 2022 | Rs 49.3bn | Rs 3.0bn | Rs 30.69 | Rs 15.00 |
| Year to Dec 2021 | Rs 42.6bn | Rs 6.0bn | Rs 60.95 | Rs 40.00 |
Balance sheet and price
Balance sheet as of Sep 2026- Total assets
- Rs 50.2bn
- Shareholders' equity
- Rs 34.8bn
- Cash & bank
- Rs 10.4bn
- Total debt
- Rs 400.8mn
- Current ratio
- 2.52
- 3-month high
- Rs 1009.02
- 3-month low
- Rs 896.88
- 1-month change
- +7.8%
- 3-month change
- +10.9%
Read more about ABOT
Other pharmaceuticals companies
- AGPAGP LtdRs 149.85P/E 12.7
- BFBIOBF Biosciences LtdRs 123.20P/E 20.0
- CPHLCiti Pharma LtdRs 63.42P/E 15.7
- CWHCCrestwell Healthcare LimitedRs 21.35
- FEROZFerozsons Laboratories LtdRs 337.68P/E 16.4
- GLAXOGlaxoSmithKline Pakistan LtdRs 315.00P/E 10.4
- HALEONHaleon Pakistan LtdRs 658.64P/E 12.7
- HINOONHighnoon Laboratories LtdRs 956.76P/E 12.1
- HPLHoehcst Pakistan LtdRs 4056.91P/E 10.4
- IBLHLIBL HealthCare LtdRs 39.86P/E 19.1
- LIVENLiven Pharma LimitedRs 31.47
- MACTERMacter International LtdRs 244.00P/E 15.3
ABOT: common questions
What is ABOT's share price?
Abbot Laboratories (Pakistan) Ltd (ABOT) last closed at Rs 1009.02 on the Pakistan Stock Exchange.
Does ABOT pay a dividend?
Yes. Abbot Laboratories (Pakistan) Ltd paid Rs 40.00 per share for the year to Dec 2025, and the stock's dividend yield is 4.0%.
What were ABOT's latest results?
In the Jul–Sep 2026 quarter, ABOT's sales rose 4% to Rs 20.6bn, from Rs 19.8bn, and profit after tax rose 40% to Rs 2.5bn, from Rs 1.8bn (compared with Jul–Sep 2025).
What is ABOT's P/E ratio?
At Rs 1009.02, ABOT trades at 11.1 times its earnings.
Figures are taken from the company's published financial statements and PSX prices. This page is information, not investment advice.

